Two Sigma Advisers’s Bio-Techne TECH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | – | Sell |
-4,000
| Closed | -$235K | – | 1921 |
|
|
2025
Q4 | $235K | Buy |
+4,000
| New | +$243K | ﹤0.01% | 2058 |
|
|
2025
Q1 | – | Sell |
-17,900
| Closed | -$1.29M | – | 2578 |
|
|
2024
Q4 | $1.29M | Sell |
17,900
-900
| -5% | -$66.1K | ﹤0.01% | 1341 |
|
|
2024
Q3 | $1.5M | Sell |
18,800
-5,300
| -22% | -$398K | ﹤0.01% | 1226 |
|
|
2024
Q2 | $1.73M | Sell |
24,100
-17,900
| -43% | -$1.32M | ﹤0.01% | 1266 |
|
|
2024
Q1 | $2.96M | Sell |
42,000
-14,300
| -25% | -$1.02M | 0.01% | 1022 |
|
|
2023
Q4 | $4.34M | Sell |
56,300
-118,668
| -68% | -$7.82M | 0.01% | 878 |
|
|
2023
Q3 | $11.9M | Sell |
174,968
-20,900
| -11% | -$1.65M | 0.03% | 427 |
|
|
2023
Q2 | $16M | Sell |
195,868
-188,600
| -49% | -$15.2M | 0.04% | 361 |
|
|
2023
Q1 | $28.5M | Buy |
384,468
+157,500
| +69% | +$12.1M | 0.07% | 251 |
|
|
2022
Q4 | $18.8M | Sell |
226,968
-59,000
| -21% | -$4.69M | 0.05% | 359 |
|
|
2022
Q3 | $20.3M | Buy |
285,968
+197,200
| +222% | +$17M | 0.06% | 319 |
|
|
2022
Q2 | $7.69M | Buy |
88,768
+26,768
| +43% | +$2.51M | 0.02% | 593 |
|
|
2022
Q1 | $6.71M | Sell |
62,000
-12,368
| -17% | -$1.28M | 0.02% | 678 |
|
|
2021
Q4 | $9.62M | Buy |
74,368
+50,368
| +210% | +$6.17M | 0.02% | 509 |
|
|
2021
Q3 | $2.91M | Buy |
+24,000
| New | +$2.92M | 0.01% | 1057 |
|
|
2020
Q4 | – | Sell |
-27,168
| Closed | -$1.68M | – | 2581 |
|
|
2020
Q3 | $1.68M | Buy |
+27,168
| New | +$1.77M | ﹤0.01% | 1254 |
|
|
2019
Q3 | – | Sell |
-9,568
| Closed | -$499K | – | 2387 |
|
|
2019
Q2 | $499K | Buy |
+9,568
| New | +$482K | ﹤0.01% | 1815 |
|
|
2018
Q3 | – | Sell |
-10,944
| Closed | -$405K | – | 2393 |
|
|
2018
Q2 | $405K | Sell |
10,944
-12,000
| -52% | -$458K | ﹤0.01% | 2001 |
|
|
2018
Q1 | $866K | Buy |
+22,944
| New | +$811K | ﹤0.01% | 1611 |
|
|
2017
Q4 | – | Sell |
-23,300
| Closed | -$704K | – | 2369 |
|
|
2017
Q3 | $704K | Buy |
+23,300
| New | +$691K | ﹤0.01% | 1623 |
|
|
2016
Q4 | – | Sell |
-23,268
| Closed | -$637K | – | 2452 |
|
|
2016
Q3 | $637K | Buy |
+23,268
| New | +$639K | ﹤0.01% | 1562 |
|
|
2015
Q1 | – | Sell |
-13,744
| Closed | -$317K | – | 2366 |
|
|
2014
Q4 | $317K | Buy |
+13,744
| New | +$315K | ﹤0.01% | 1917 |
|
|
2014
Q3 | – | Sell |
-10,944
| Closed | -$253K | – | 2651 |
|
|
2014
Q2 | $253K | Buy |
+10,944
| New | +$242K | ﹤0.01% | 2113 |
|
|
2014
Q1 | – | Sell |
-28,796
| Closed | -$681K | – | 2526 |
|
|
2013
Q4 | $681K | Sell |
28,796
-190,400
| -87% | -$4.13M | 0.01% | 1389 |
|
|
2013
Q3 | $4.39M | Sell |
219,196
-171,184
| -44% | -$3.25M | 0.05% | 366 |
|
|
2013
Q2 | $6.74M | Buy |
+390,380
| New | +$6.48M | 0.1% | 197 |
|
Other funds holding TECH
VCM
VPM
MC
Two Sigma Advisers's TECH Position: Q1 2026 in Review
Two Sigma Advisers sold out of Bio-Techne (TECH) in Q1 2026, closing a stake of 4,000 shares — an estimated $235K sold.
Two Sigma Advisers first reported a position in TECH in Q2 2013 and held it in 26 quarters. The position peaked at $28.5M in Q1 2023. 582 funds tracked by Wall St. Rank hold TECH as of Q1 2026.
- Two Sigma Advisers reported no remaining Bio-Techne position as of Q1 2026 after selling out during the quarter.
- Two Sigma Advisers sold 4,000 Bio-Techne shares in Q1 2026, an estimated $235K.
- Two Sigma Advisers first reported a position in Bio-Techne in Q2 2013 and held it in 26 quarters.
- Two Sigma Advisers's Bio-Techne position peaked at $28.5M in Q1 2023.
- 582 funds tracked by Wall St. Rank held Bio-Techne as of Q1 2026.
Based on Two Sigma Advisers's 13F filing for Q1 2026.